 |
인쇄하기
취소
|
KFDA approves new indication of Crestor, “therosclerosis”
AstraZeneca Korea says that the Korea Food and Drug Administration has approved Crestor (rosuvastatin calcium) as an adjunct to diet to slow the progression of atherosclerosis in patients with elevated cholesterol.
According to the company, this new indication gives Crestor an important differentiator from competitors in the cholesterol-lowering market
Atherosclerosis is the progressive ...
According to the company, this new indication gives Crestor an important differentiator from competitors in the cholesterol-lowering market
Atherosclerosis is the progressive ...
Fees
- Email service daily and homepage access.
- $300 per month.
- 5 Email holders per each company.
- Anual contract base.
Copyright Yakup.com All rights reserved.
약업닷컴의 모든 컨텐츠는 저작권법의 보호를 받습니다. 무단 전재⋅복사⋅배포 등을 금합니다.
약업닷컴의 모든 컨텐츠는 저작권법의 보호를 받습니다. 무단 전재⋅복사⋅배포 등을 금합니다.